PMID- 33840401 OWN - NLM STAT- MEDLINE DCOM- 20210413 LR - 20210714 IS - 1008-8830 (Print) IS - 1008-8830 (Linking) VI - 23 IP - 4 DP - 2021 Apr TI - [Pediatric expert consensus on the application of intravenous immunoglobulin in children with hematological/neoplastic diseases]. PG - 319-327 AB - Intravenous immunoglobulin (IVIG) has been widely used in chemotherapy for hematological malignancies, targeted therapy, and hematopoietic stem cell transplantation; however, there are still no available guidelines or consensus statements on the application of IVIG in pediatric hematological/neoplastic diseases at present in China and overseas. This consensus is developed based on the research advances in the application of IVIG in pediatric hematological/neoplastic diseases across the world and provides detailed recommendations for the clinical application of IVIG in pediatric hematological/neoplastic diseases and the prevention and treatment of related adverse reactions. CN - Pediatric Branch of Guangdong Medical Association CN - Editorial Department of Chinese Journal of Contemporary Pediatrics LA - chi PT - Journal Article PL - China TA - Zhongguo Dang Dai Er Ke Za Zhi JT - Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics JID - 100909956 RN - 0 (Immunoglobulins, Intravenous) SB - IM MH - Child MH - China MH - Consensus MH - *Hematologic Neoplasms/drug therapy MH - *Hematopoietic Stem Cell Transplantation MH - Humans MH - Immunoglobulins, Intravenous/therapeutic use PMC - PMC8050546 COIS- 利益冲突声明:所有作者均声明不存在利益冲突。 EDAT- 2021/04/13 06:00 MHDA- 2021/04/14 06:00 PMCR- 2021/04/15 CRDT- 2021/04/12 05:30 PHST- 2021/04/12 05:30 [entrez] PHST- 2021/04/13 06:00 [pubmed] PHST- 2021/04/14 06:00 [medline] PHST- 2021/04/15 00:00 [pmc-release] AID - 10.7499/j.issn.1008-8830.2101174 [pii] AID - zgddekzz-23-4-319 [pii] AID - 10.7499/j.issn.1008-8830.2101174 [doi] PST - ppublish SO - Zhongguo Dang Dai Er Ke Za Zhi. 2021 Apr;23(4):319-327. doi: 10.7499/j.issn.1008-8830.2101174.